Cargando…
Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing
Introduction: Acute cellular rejection (ACR) of heart allografts represents the most common reason for graft failure. Endomyocardial biopsies (EMB) are still subject to substantial interobserver variability. Novel biomarkers enabling precise ACR diagnostics may decrease interobserver variability. We...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912472/ https://www.ncbi.nlm.nih.gov/pubmed/31698874 http://dx.doi.org/10.3390/cells8111400 |
_version_ | 1783479464036925440 |
---|---|
author | Nováková, Tereza Macháčková, Táňa Novák, Jan Hude, Petr Godava, Július Žampachová, Víta Oppelt, Jan Zlámal, Filip Němec, Petr Bedáňová, Helena Slabý, Ondřej Bienertová-Vašků, Julie Špinarová, Lenka Krejčí, Jan |
author_facet | Nováková, Tereza Macháčková, Táňa Novák, Jan Hude, Petr Godava, Július Žampachová, Víta Oppelt, Jan Zlámal, Filip Němec, Petr Bedáňová, Helena Slabý, Ondřej Bienertová-Vašků, Julie Špinarová, Lenka Krejčí, Jan |
author_sort | Nováková, Tereza |
collection | PubMed |
description | Introduction: Acute cellular rejection (ACR) of heart allografts represents the most common reason for graft failure. Endomyocardial biopsies (EMB) are still subject to substantial interobserver variability. Novel biomarkers enabling precise ACR diagnostics may decrease interobserver variability. We aimed to identify a specific subset of microRNAs reflecting the presence of ACR. Patients and Methods: Monocentric retrospective study. A total of 38 patients with the anamnesis of ACR were identified and for each patient three consecutive samples of EMB (with, prior and after ACR) were collected. Sixteen trios were used for next-generation sequencing (exploratory cohort); the resting 22 trios were used for validation with qRT-PCR (validation cohort). Statistical analysis was performed using R software. Results: The analysis of the exploration cohort provided the total of 11 miRNAs that were altered during ACR, the three of which (miR-144, miR-589 and miR-182) were further validated in the validation cohort. Using the levels of all 11 miRNAs and principal component analysis, an ACR score was created with the specificity of 91% and sensitivity of 68% for detecting the presence of ACR in the EMB sample. Conclusion: We identified a set of microRNAs altered in endomyocardial biopsies during ACR and using their relative levels we created a diagnostic score that can be used for ACR diagnosis. |
format | Online Article Text |
id | pubmed-6912472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69124722020-01-02 Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing Nováková, Tereza Macháčková, Táňa Novák, Jan Hude, Petr Godava, Július Žampachová, Víta Oppelt, Jan Zlámal, Filip Němec, Petr Bedáňová, Helena Slabý, Ondřej Bienertová-Vašků, Julie Špinarová, Lenka Krejčí, Jan Cells Article Introduction: Acute cellular rejection (ACR) of heart allografts represents the most common reason for graft failure. Endomyocardial biopsies (EMB) are still subject to substantial interobserver variability. Novel biomarkers enabling precise ACR diagnostics may decrease interobserver variability. We aimed to identify a specific subset of microRNAs reflecting the presence of ACR. Patients and Methods: Monocentric retrospective study. A total of 38 patients with the anamnesis of ACR were identified and for each patient three consecutive samples of EMB (with, prior and after ACR) were collected. Sixteen trios were used for next-generation sequencing (exploratory cohort); the resting 22 trios were used for validation with qRT-PCR (validation cohort). Statistical analysis was performed using R software. Results: The analysis of the exploration cohort provided the total of 11 miRNAs that were altered during ACR, the three of which (miR-144, miR-589 and miR-182) were further validated in the validation cohort. Using the levels of all 11 miRNAs and principal component analysis, an ACR score was created with the specificity of 91% and sensitivity of 68% for detecting the presence of ACR in the EMB sample. Conclusion: We identified a set of microRNAs altered in endomyocardial biopsies during ACR and using their relative levels we created a diagnostic score that can be used for ACR diagnosis. MDPI 2019-11-06 /pmc/articles/PMC6912472/ /pubmed/31698874 http://dx.doi.org/10.3390/cells8111400 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nováková, Tereza Macháčková, Táňa Novák, Jan Hude, Petr Godava, Július Žampachová, Víta Oppelt, Jan Zlámal, Filip Němec, Petr Bedáňová, Helena Slabý, Ondřej Bienertová-Vašků, Julie Špinarová, Lenka Krejčí, Jan Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing |
title | Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing |
title_full | Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing |
title_fullStr | Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing |
title_full_unstemmed | Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing |
title_short | Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing |
title_sort | identification of a diagnostic set of endomyocardial biopsy micrornas for acute cellular rejection diagnostics in patients after heart transplantation using next-generation sequencing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912472/ https://www.ncbi.nlm.nih.gov/pubmed/31698874 http://dx.doi.org/10.3390/cells8111400 |
work_keys_str_mv | AT novakovatereza identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT machackovatana identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT novakjan identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT hudepetr identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT godavajulius identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT zampachovavita identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT oppeltjan identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT zlamalfilip identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT nemecpetr identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT bedanovahelena identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT slabyondrej identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT bienertovavaskujulie identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT spinarovalenka identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing AT krejcijan identificationofadiagnosticsetofendomyocardialbiopsymicrornasforacutecellularrejectiondiagnosticsinpatientsafterhearttransplantationusingnextgenerationsequencing |